Smoking cessation interventions in COPD: A networkmeta-analysis of randomised trials

European Respiratory Journal

Volumn 34, Issue 3, 2009, Pages 634-640

  Strassmann, R ^a   Bausch, B ^a   Spaar, A ^a   Kleijnen, J ^c,d   Braendli, O ^b   Puhan, M A ^a,e  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c KLEIJNEN SYSTEMATIC REVIEWS LTD   (United Kingdom)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Chronic obstructive pulmonary disease; Mortality; Network meta analysis; Prolonged abstinence rates; Randomised trials; Smoking cessation

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; IPRATROPIUM BROMIDE; NORTRIPTYLINE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; META ANALYSIS; MORTALITY; NICOTINE REPLACEMENT THERAPY; PATIENT CARE; PATIENT COUNSELING; PRIORITY JOURNAL; SMOKING CESSATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; DIRECTIVE COUNSELING; HUMANS; NICOTINIC AGONISTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 70349159020     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00167708     Document Type: Article

References (31)

1. American Thoracic Society/European Respiratory Society. Standards for the diagnosis and treatment of patients with chronic obstructive pulmonary disease. 2004. www.ersnet.org/lrPresentations/copd/files/main/index.html Date last accessed: November 4, 2008.
2. Connett JE, Murray RP, Buist AS, et al. Changes in smoking status affect women more than men: results of the lung health study. Am J Epidemiol 2003; 157: 973-979.
3. Kanner RE, Connett JE, Williams DE, et al. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the lung health study. Am J Med 1999; 106: 410-416.
4. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The lung health study. Am J Respir Crit Care Med 2000; 161: 381-390. (Pubitemid 30129442)
5. Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med 2007; 101: 1305-1312. (Pubitemid 46667662)
6. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: A randomized clinical trial. Ann Intern Med 2005; 142: 233-239. (Pubitemid 40216240)
7. Wagena EJ, van der Meer RM, Ostelo RJ, et al. The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review. Respir Med 2004; 98: 805-815.
8. Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Database Syst Rev 2004: 4; CD000165.
9. Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database Syst Rev 2005: 3; CD001118.
10. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2005: 2; CD001007. (Pubitemid 41075736)
11. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2005: 2; CD001292.
12. Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; 3: CD000146.
13. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007; 1: CD000031.
14. Jimenez-Ruiz CA, Masa F, Miravitlles M, et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001; 119: 1365-1370. (Pubitemid 32686016)
15. Clark MA, Hogan JW, Kviz FJ, et al. Age and the role of symptomatology in readiness to quit smoking. Addict Behav 1999; 24: 1-16.
16. Walters N, Coleman T. Comparison of the smoking behaviour and attitudes of smokers who attribute respiratory symptoms to smoking with those who do not. Br J Gen Prac 2002; 52: 132-134. (Pubitemid 34130174)
17. Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005; 331: 897-900.
18. Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997; 50: 683-691. (Pubitemid 27341818)
19. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004; 23: 3105-3124. (Pubitemid 39334902)
20. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002; 21: 2313-2324. (Pubitemid 34905450)
21. Puhan MA, Bachmann LM, Kleijnen J, et al. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis. BMC Med 2009; 7: 2.
22. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
23. Brandt CJ, Ellegaard H, Joensen M, et al. Effect of diagnosis of "smoker's lung". RYLUNG Group. Lancet 1997; 349: 253.
24. Crowley TJ, Macdonald MJ, Walter MI. Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients. Psychopharmacology 1995; 119: 193-204.
25. Hilberink SR, Jacobs JE, Bottema BJ, et al. Smoking cessation in patients with COPD in daily general practice (SMOCC): six months' results. Prev Med 2005; 41: 822-827.
26. Pederson LL, Wanklin JM, Lefcoe NM. The effects of counseling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial. Int J Addic 1991; 26: 107-119.
27. Tashkin D, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 2001; 357: 1571-1575. (Pubitemid 32488814)
28. Tonnesen P, Mikkelsen K, Bremann L. Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest 2006; 130: 334-342. (Pubitemid 44266998)
29. Wagena EJ, Knipschild PG, Huibers MJH, et al. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med 2005; 165: 2286-2292. (Pubitemid 41549926)
30. Pocock SJ. Safety of drug-eluting stents: demystifying network meta-analysis. Lancet 2008; 370: 2099-2100.
31. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008; 63: 831-838.